Anzeige
Mehr »
Login
Donnerstag, 30.05.2024 Börsentäglich über 12.000 News von 688 internationalen Medien
Die neuen Aktien-Stars der nächsten Rallye-Stufe im Uransektor
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2DU6V | ISIN: US1897631057 | Ticker-Symbol: C97
Tradegate
29.05.24
16:08 Uhr
0,995 Euro
+0,050
+5,29 %
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
CO-DIAGNOSTICS INC Chart 1 Jahr
5-Tage-Chart
CO-DIAGNOSTICS INC 5-Tage-Chart
RealtimeGeldBriefZeit
0,9600,99517:53
0,9700,99517:50

Aktuelle News zur CO-DIAGNOSTICS Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
10.05.Earnings call: Co-Diagnostics Q1 2024 financial results and updates2
10.05.Co-Diagnostics, Inc. (CODX) Q1 2024 Earnings Call Transcript1
09.05.Co-Diagnostics, Inc. - 10-Q, Quarterly Report1
09.05.Co-Diagnostics, Inc. - 8-K, Current Report1
09.05.Co-Diagnostics, Inc. Reports First Quarter 2024 Financial Results620SALT LAKE CITY, May 9, 2024 /PRNewswire/ -- Co-Diagnostics, Inc. (NASDAQ: CODX) ("Co-Dx," or the "Company"), a molecular diagnostics company with a unique, patented platform for the development...
► Artikel lesen
02.04.Peering Into Co-Diagnostics' Recent Short Interest2
15.03.Co-Diagnostics, Inc. (CODX) Q4 2023 Earnings Call Transcript1
14.03.Co-Diagnostics Inc reports results for the quarter ended in December - Earnings Summary3
14.03.Co-Diagnostics GAAP EPS of -$1.20 misses by $0.30, revenue of $6.8M misses by $0.08M2
14.03.Co-Diagnostics: Q4 Earnings Insights2
14.03.Co-Diagnostics, Inc. - 10-K, Annual Report2
14.03.Co-Diagnostics, Inc. - 8-K, Current Report2
14.03.Co-Diagnostics, Inc. Reports Full Year 2023 Financial Results1.004SALT LAKE CITY, March 14, 2024 /PRNewswire/ -- Co-Diagnostics, Inc. (NASDAQ: CODX), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic...
► Artikel lesen
13.03.Earnings Preview: Co-Diagnostics2
07.03.Co-Diagnostics JV gains India approval for flu test kit3
07.03.Co-Diagnostics, Inc. JV CoSara Receives Clearance from Indian Regulators for Influenza Multiplex PCR Test294The clinical laboratory real-time PCR multiplex test was designed using Co-Dx Co-Primers and licensed by the CDSCO for use in diagnostic procedures SALT LAKE CITY, March 7, 2024 /PRNewswire/ --...
► Artikel lesen
27.12.23Co-Diagnostics applies for FDA okay of COVID-19 test, stock rallies 17%12
27.12.23Co-Diagnostics Completes EUA Submission To FDA For Co-Dx PCR Pro5
09.11.23Co-Diagnostics, Inc. Reports Third Quarter 2023 Financial Results181Receives grant award from the Bill & Melinda Gates Foundation in the amount of $9.0M for the development of tuberculosis test on Co-Dx PCR platform. SALT LAKE CITY, Nov. 9, 2023 /PRNewswire/ --...
► Artikel lesen
10.08.23Co-Diagnostics, Inc. Reports Second Quarter 2023 Financial Results278Co-Dx receives grant awards from the Bill & Melinda Gates Foundation; NIH RADx® Tech to develop tests on our new Co-Dx PCR Home platform SALT LAKE CITY, Aug. 10, 2023 /PRNewswire/ -- Co-Diagnostics...
► Artikel lesen
20 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1